The DOI matches its Crossref record; 237 of the 237 references it cites were found in a registry or an index.
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Open accessAbstract
Fungal infections are a major contributor to infectious disease-related deaths across the globe. Candida species are among the most common causes of invasive mycotic disease, with Candida albicans reigning as the leading cause of invasive candidiasis. Given that fungi are eukaryotes like their human host, the number of unique molecular targets that can be exploited for antifungal development remains limited. Currently, there are only three major classes of drugs approved for the treatment of invasive mycoses, and the efficacy of these agents is compromised by the development of drug resistance in pathogen populations. Notably, the emergence of additional drug-resistant species, such as Candida auris and Candida glabrata, further threatens the limited armamentarium of antifungals available to treat these serious infections. Here, we describe our current arsenal of antifungals and elaborate on the resistance mechanisms Candida species possess that render them recalcitrant to therapeutic intervention. Finally, we highlight some of the most promising therapeutic strategies that may help combat antifungal resistance, including combination therapy, targeting fungal-virulence traits, and modulating host immunity. Overall, a thorough understanding of the mechanistic principles governing antifungal drug resistance is fundamental for the development of novel therapeutics to combat current and emerging fungal threats.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, large-scale genomic alterations, including aneuploidy, loss-of-heterozygosity (LOH), and chromosomal rearrangements, can affect the expression of drug targets, efflux pumps, and other resistance factors (7).”
From Potential role of lysine acetylation in the stepwise adaptation of Candida albicans to fluconazole (2025) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“These mutations lead to either the overexpression of the enzyme itself (14) or alterations in its activity that can lower fluconazole’s binding strength, leading to reduced drug effectiveness (15).”
From Candida albicans enhances iron uptake to maintain fluconazole resistance (2025) · cites this paper as [15]
In the citing paper
“the only new class of antifungal drugs developed in decades, the echinocandins, displays negligible antifungal activity against Cryptococcus spp.”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
In the citing paper
“Treatment options for invasive cryptococcal infection are limited, given that Cryptococcus spp. are intrinsically resistant to echinocandins and that they employ an arsenal of defences that enable resistance to azoles2,8.”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
In the citing paper
“the polyene amphotericin B has been the primary treatment for cryptococcal infection for more than half a century, despite the fact that it causes substantial toxicity and that its availability is limited by economic and logistical constraints2,4”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
In the citing paper
“current antifungal drug treatments for invasive fungal infections are limited to polyenes, azoles and echinocandins2”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
In the citing paper
“Combination therapy has the potential to confer enhanced efficacy and fungal selectivity while reducing vulnerability to the evolution of resistance2.”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lead- and drug-like compounds: the rule-of-five revolution
Lipinski, C. A. (2004) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2004.11.007 · Cited by 6,455
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
The Genetic Landscape of a Cell
Costanzo, M., Baryshnikova, A., Bellay, J., Kim, Y., Spear, E. D., Sevier, C. S., Ding, H., Koh, J. L. Y., Toufighi, K., Mostafavi, S., et al. (2010) · Science · doi:10.1126/science.1180823 · Cited by 2,162
Candida albicans pathogenicity mechanisms
Mayer, F. L., Wilson, D., & Hube, B. (2013) · Virulence · doi:10.4161/viru.22913 · Cited by 1,848
HSP90 at the hub of protein homeostasis: emerging mechanistic insights
Taipale, M., Jarosz, D. F., & Lindquist, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2918 · Cited by 1,818
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
Fisher, M. C., Hawkins, N. J., Sanglard, D., & Gurr, S. J. (2018) · Science · doi:10.1126/science.aap7999 · Cited by 1,555
Research works printed but not linked: 1
- Besterman, J.; Nguyen, D. T.; Ste-Croix, H. MGCD290, an Oral Fungal Hos2 Inhibitor, Enhances the Antifungal Properties of Fluconazole Following Multiple-or Single-Dose Oral Administration in Pre-and Post-Infection Settings. In Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) ; MethylGene, Inc.: San Francisco, CA, 2012; Vol. Poster M-1711.
Cited by
Sorted by citations
Items 101–200 of 823
Antifungal Resistance in Clinical Isolates of Candida glabrata in Ibero-America
Martínez-Herrera, E. O., León, M. G. F.-D., Hernández‐Castro, R., García-Salazar, E., Arenas, R., Ocharan-Hernández, M. E., & Rodríguez‐Cerdeira, C. (2021) · Journal of Fungi · doi:10.3390/jof8010014 · Cited by 33
Molecular association of Candida albicans and vulvovaginal candidiasis: focusing on a solution
David, H., & Solomon, A. P. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1245808 · Cited by 34
Kumari, S., Wan, F., Thakur, A., Singh, S. P., & Thakur, P. (2023) · Ceramics International · doi:10.1016/j.ceramint.2023.11.071 · Cited by 28
Yin, K., Li, R., Zhang, S., Sun, Y., Huang, L., Jiang, M., Xu, D., & Xu, W. (2025) · Advanced Science · doi:10.1002/advs.202412488 · Cited by 28
Current and promising pharmacotherapeutic options for candidiasis
Scorzoni, L., Fuchs, B. B., Junqueira, J. C., & Mylonakis, E. E. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1873951 · Cited by 30
Shafiei, M., Toreyhi, H., Firoozpour, L., Akbarzadeh, T., Amini, M., Hosseinzadeh, E., Hashemzadeh, M., Peyton, L., Lotfali, E., & Foroumadi, A. (2021) · ACS Omega · doi:10.1021/acsomega.1c04016 · Cited by 28
El-Ganiny, A. M., Kamel, H. A., Yossef, N. E., Mansour, B., & El-Baz, A. M. (2022) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2022.01.011 · Cited by 28
Prajapati, J., Goswami, D., Dabhi, M., Acharya, D., & Rawal, R. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106237 · Cited by 28
Wei, Y., Wang, Z., Liu, Y., Liao, B., Zong, Y., Shi, Y., Liao, M., Wang, J., Zhou, X., Cheng, L., et al. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-12300-7 · Cited by 29
Baloch, H., Siddiqua, A., Nawaz, A., Latif, M. S., Zahra, S. Q., Alomar, S. Y., Ahmad, N., & Elsayed, T. M. A. (2023) · Gels · doi:10.3390/gels9040284 · Cited by 28
Application of anti-fungal vaccines as a tool against emerging anti-fungal resistance
Kumar, R., & Srivastava, V. (2023) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2023.1241539 · Cited by 29
The progress and future of the treatment of Candida albicans infections based on nanotechnology
Gao, Y., Cao, Q., Xiao, Y., Wu, Y., Ding, L., Huang, H., Li, Y., Yang, J., & Meng, L. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02841-6 · Cited by 27
Herman, A., & Herman, A. P. (2021) · Antibiotics · doi:10.3390/antibiotics10060655 · Cited by 34
Li, S., Wang, Y., Zhou, J., Wang, J., Zhang, M., & Chen, H. (2023) · Molecules · doi:10.3390/molecules28073098 · Cited by 27
Advancing Vaccine Strategies against Candida Infections: Exploring New Frontiers
Kaur, G., Chawla, S., Kumar, P., & Singh, R. (2023) · Vaccines · doi:10.3390/vaccines11111658 · Cited by 26
Cheng, Z., Kandekar, U., Ma, X., Bhabad, V., Pandit, A. P., Liu, L., Luo, J., Munot, N. M., Chorage, T. V., Patil, A., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1353791 · Cited by 26
Yu, L., Shen, N., Ren, J., Xin, H., & Cui, Y. (2024) · Fitoterapia · doi:10.1016/j.fitote.2024.106326 · Cited by 25
de Oliveira, H. C., Rossi, S. A., García-Barbazán, I., Zaragoza, Ó., & Trevijano‐Contador, N. (2021) · Journal of Fungi · doi:10.3390/jof7100831 · Cited by 27
Inhibitory effect of ficin on Candida albicans biofilm formation and pre-formed biofilms
Yu, J., Wang, F., Shen, Y., Yu, F., Qiu, L., Zhang, L., Chen, Y., Yuan, Q., Zhang, H., Sun, Y., et al. (2022) · BMC Oral Health · doi:10.1186/s12903-022-02384-y · Cited by 25
Biopolymer composites for removal of toxic organic compounds in pharmaceutical effluents – a review
Simelane, N. P., Asante, J. K. O., Ndibewu, P. P., Mramba, A. S., & Sibali, L. L. (2022) · Carbohydrate Polymer Technologies and Applications · doi:10.1016/j.carpta.2022.100239 · Cited by 25
Unveiling the menace: a thorough review of potential pandemic fungal disease
Jafarlou, M. (2024) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2024.1338726 · Cited by 24
Robbins, N., & Cowen, L. E. (2021) · Current Biology · doi:10.1016/j.cub.2021.09.071 · Cited by 24
Self-citationWen, W., Yu, X., Zhou, B., Tian, M., Li, G., Shi, Y., & Tan, L. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c18884 · Cited by 24
Antifungal resistance: Emerging mechanisms and implications (Review)
Kadariswantiningsih, I. N., Empitu, M. A., Santosa, T., & Alimu, Y. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13612 · Cited by 26
Recent progress on anti-Candida natural products
Sun, F., Li, M., Liang, G. U., Wang, M., & Yang, M. (2021) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(21)60057-2 · Cited by 24
Sadanandan, B., Vijayalakshmi, V., Lokesh, K. N., Shetty, K., Joglekar, A. P., Ashrit, P., & Hemanth, B. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.15402 · Cited by 24
Mixed Fungal Biofilms: From Mycobiota to Devices, a New Challenge on Clinical Practice
Costa, P. D. S., Prado, A., Bagon, N. P., Negri, M., & Svidzinski, T. I. E. (2022) · Microorganisms · doi:10.3390/microorganisms10091721 · Cited by 25
Xue, P., Sang, R., Li, N., Du, S., Kong, X., Tai, M., Jiang, Z., & Chen, Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1119037 · Cited by 25
Progress in the application of nanoparticles for the treatment of fungal infections: A review
Zhu, X., Chen, Y.-M., Yu, D. B., Fang, W., Liao, W., & Pan, W. (2023) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2023.2285764 · Cited by 25
Arumugam, G., Durairaj, S., Gonçale, J. C., do Carmo, P. H. F., Garcia, M. T., da Silva, N. S., Borges, B. M., Loures, F. V., Ghosh, D., Vivanco, J. F., et al. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c02694 · Cited by 24
Ramos, L. S., Barbosa, P. F., Lorentino, C. M. A., Lima, J. C., Braga, A. L., Lima, R., Giovanini, L., Casemiro, A. L., Siqueira, N. L. M., da Costa, S. C., et al. (2025) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2025.100354 · Cited by 24
Demin, K. A., Refeld, A. G., Bogdanova, A. A., Prazdnova, E. V., Popov, I. V., Kutsevalova, O. Y., Ermakov, A. M., Bren, A. B., Rudoy, D. V., Chistyakov, V. A., et al. (2021) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09776-6 · Cited by 24
In vivo active organometallic-containing antimycotic agents
Rubbiani, R., Weil, T., Tocci, N., Mastrobuoni, L., Jeger, S., Moretto, M., Ng, J., Lin, Y., Hess, J., Ferrari, S. M., et al. (2021) · RSC Chemical Biology · doi:10.1039/d1cb00123j · Cited by 24
Discovery of a novel antifungal agent: All‐hydrocarbon stapling modification of peptide Aurein1.2
Zheng, M., Chen, H., Li, X., Chen, S., Shi, Y., & Hu, H. (2023) · Journal of Peptide Science · doi:10.1002/psc.3533 · Cited by 23
Zhao, Y. G., Liu, S., Shi, Z., Zhu, H., Li, M., & Yu, Q. (2022) · Nano Research · doi:10.1007/s12274-022-4211-z · Cited by 23
Stanković, M., Kljun, J., Stevanović, N. L., Lazic, J., Bogojević, S. Š., Vojnović, S., Zlatar, M., Nikodinović‐Runić, J., Turel, I., Djuran, M. I., et al. (2024) · Dalton Transactions · doi:10.1039/d3dt03010e · Cited by 24
Logviniuk, D., Jaber, Q. Z., Dobrovetsky, R., Kozer, N., Księżopolska, E., Gabaldón, T., Carmeli, S., & Fridman, M. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c00269 · Cited by 22
Synthesis, Biological Activity and Molecular Docking Studies of Novel Nicotinic Acid Derivatives
Paruch, K., Biernasiuk, A., Khyluk, D., Paduch, R., Wujec, M., & Popiołek, Ł. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052823 · Cited by 22
Jaber, Q. Z., Logviniuk, D., Yona, A., & Fridman, M. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00060 · Cited by 24
Fang, Z., Guo, Z., Fan, Y., Li, S., Han, Z., & Liu, Y. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.128902 · Cited by 22
Alrashidi, A. A., Jafar, M., Higgins, N., Mulligan, C., Varricchio, C., Moseley, R., Celiksoy, V., Houston, D. M. J., & Heard, C. M. (2021) · Biomolecules · doi:10.3390/biom11121889 · Cited by 21
Bravo-Chaucanés, C. P., Vargas‐Casanova, Y., Chitiva, L. C., Ceballos-Garzón, A., Costa, G. M., & Parra‐Giraldo, C. M. (2022) · Journal of Fungi · doi:10.3390/jof8080784 · Cited by 21
Liu, S., Jiang, L., Miao, H., Lv, Y., Zhang, Q., Ma, M., Duan, W., Huang, Y., & Wei, X. (2022) · Biofouling · doi:10.1080/08927014.2022.2153332 · Cited by 21
Small molecules restore azole activity against drug-tolerant and drug-resistant Candida isolates
Alabi, P., Gautier, C., Murphy, T. P., Gu, X., Lepas, M., Aimanianda, V., Sello, J. K., & Ene, I. V. (2023) · mBio · doi:10.1128/mbio.00479-23 · Cited by 22
Antifungal Efficacy of Antimicrobial Peptide Octominin II against Candida albicans
Jayasinghe, J. N. C., Whang, I., & Zoysa, M. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814053 · Cited by 22
Górka, K., & Kubiński, K. (2023) · Applied Sciences · doi:10.3390/app14010115 · Cited by 21
Miranda, F., Tavares, V. K. F., Silva, D. M., Milhan, N. V. M., Neto, N. F. A., Gomes, M. P., Pessoa, R. S., & Koga‐Ito, C. Y. (2024) · Plasma Chemistry and Plasma Processing · doi:10.1007/s11090-024-10475-7 · Cited by 21
Development of photodynamic therapy in treating oral diseases
Wang, L., Chen, Q., & Liu, D. (2025) · Frontiers in Oral Health · doi:10.3389/froh.2024.1506407 · Cited by 21
Tan, C., Wu, A., & Li, C. (2025) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2025.102947 · Cited by 20
Eradication of Fungi Using MoSe2/Chitosan Nanosheets
Saha, S., Gilliam, M. S., Wang, Q. H., & Green, A. A. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c01013 · Cited by 20
Lee, H., Choi, S. H., Oh, J., Koo, J., Lee, H. J., Cho, S., Shin, J. H., Lee, H. K., Kim, S., Lee, C. H., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01253-21 · Cited by 22
Genomic Variation-Mediating Fluconazole Resistance in Yeast
Wang, W., Cai, H., Qu, S.-Y., Lin, W., Liang, C., Liu, H., Xie, Z., & Yuan, Y. (2022) · Biomolecules · doi:10.3390/biom12060845 · Cited by 22
Wang, S., Wang, P., Liu, J., Yang, C., Wang, Q., Su, M., Wei, M., & Gu, L. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s373991 · Cited by 20
Lei, J., Huang, J., Xin, C., Liu, F., Zhang, J., Xie, Y., Mao, Y., Chen, W., & Song, Z. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03801-22 · Cited by 20
Antimicrobial activity and biocompatibility of alpha-silver tungstate nanoparticles
de Annunzio, S. R., Moraes, B., Assis, M., Barbugli, P. A., de Oliveira, V. H. F. P., Longo, E., & Vergani, C. E. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42648 · Cited by 19
Deciphering the oxidative stress response in Candida albicans
Arribas, V., Gil, C., & Molero, G. (2025) · Fungal Biology Reviews · doi:10.1016/j.fbr.2025.100427 · Cited by 20
Agrochemical fungicides as environmental drivers of antifungal resistance
Parra, A. L. C., Pereira, V. C., Freitas, A. S., de Souza-Filho, M. A., Viera, A. S. A., Diógenes, E. M., Sidrim, J. J. C., Guedes, G. M. D. M., Cordeiro, R. D. A., Morio, F., et al. (2025) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2025.180385 · Cited by 19
Wu, H., Yin, X., Zhao, X., Wu, Z., Xiao, Y., Di, Q., Sun, P., Tang, H., Quan, J., & Chen, W. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102461 · Cited by 19
Li, G., Lv, K., Pan, X., Zhou, S., Xing, H., Xu, J., Ma, D., Hu, Y., & Xu, H. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.11.006 · Cited by 19
Wani, M. Y., Alghamidi, M. S. S., Srivastava, V., Ahmad, A., Aqlan, F. M., & Al‐Bogami, A. S. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106562 · Cited by 19
Biochemical, Antioxidant Properties and Antimicrobial Activity of Steno-Endemic Origanum onites
Canlı, K., Bozyel, M. E., Turu, D., Benek, A., Şimşek, Ö., & Altuner, E. M. (2023) · Microorganisms · doi:10.3390/microorganisms11081987 · Cited by 19
MacAlpine, J., Liu, Z., Hossain, S., Whitesell, L. J., Robbins, N., & Cowen, L. E. (2023) · mBio · doi:10.1128/mbio.02183-23 · Cited by 20
Self-citationDiscovery of Piperidol Derivatives for Combinational Treatment of Azole-Resistant Candidiasis
Yang, W., Tu, J., Ji, C., Li, Z., Han, G., Liu, N., Li, J., & Sheng, C. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00849 · Cited by 19
Design, Synthesis and Antifungal Activity of Stapled Aurein1.2 Peptides
Zheng, M., Wang, R., Chen, S., Zou, Y., Yan, L., Zhao, L., & Li, X. (2021) · Antibiotics · doi:10.3390/antibiotics10080956 · Cited by 19
Lee, Y., Liston, S. D., Lee, D., Robbins, N., & Cowen, L. E. (2022) · iScience · doi:10.1016/j.isci.2022.104432 · Cited by 18
Self-citationHussen, N. H., Hussein, L. B., Hasan, A. H., Hamid, S. J., Abdl, C. O., Sarkar, B., Muhammed, K. A., & Muhamad, D. (2025) · Aspects of Molecular Medicine · doi:10.1016/j.amolm.2025.100066 · Cited by 18
Restoring mucosal barrier homeostasis by in situ formation of a living-synthetic therapeutic coating
Yu, W., Luo, H., Han, B. R., Lin, S., Li, Q., Xue, R., Tang, H., Jia, X., Wang, L., & Liu, J. (2025) · Nature Communications · doi:10.1038/s41467-025-63110-0 · Cited by 18
Azam, F., Khan, M. A., Khan, A., Ahmad, S., Zofair, S. F. F., & Younus, H. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.04.060 · Cited by 18
Gil, F., Laiolo, J., Bayona-Pacheco, B. L., Cannon, R. D., Ferreira‐Pereira, A., & Carpinella, M. C. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03745-4 · Cited by 19
Zapata-Zapata, C., Loaiza-Oliva, M., Pabón, M. C. M., Stashenko, E. E., & Mesa-Arango, A. C. (2022) · Molecules · doi:10.3390/molecules27206837 · Cited by 18
Activity and mechanism of action of antimicrobial peptide ACPs against Candida albicans
Zou, K., Yin, K., Ren, S., Zhang, R., Zhang, L., Zhao, Y., & Li, R. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122767 · Cited by 18
Brilacidin, a novel antifungal agent against Cryptococcus neoformans
Diehl, C., Pinzan, C. F., de Castro, P. A., Delbaje, E., García-Carnero, L. C., Sánchez‐León, E., Bhalla, K., Kronstad, J. W., Kim, D.-G., Doering, T. L., et al. (2024) · mBio · doi:10.1128/mbio.01031-24 · Cited by 19
Washington, E., Zhou, Y., Hsu, A. L., Petrovich, M., Tenor, J. L., Toffaletti, D. L., Guan, Z., Perfect, J. R., Borgnia, M. J., Bartesaghi, A., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2314087121 · Cited by 18
Antifungal activities of Equol against Candida albicans in vitro and in vivo
Wang, F., Zhang, J., Zhang, Q., Song, Z., & Xin, C. (2024) · Virulence · doi:10.1080/21505594.2024.2404256 · Cited by 18
Balancing Positive and Negative Selection: In Vivo Evolution of Candida lusitaniae MRR1
Demers, E. G., Stajich, J., Ashare, A., Occhipinti, P., & Hogan, D. A. (2021) · mBio · doi:10.1128/mbio.03328-20 · Cited by 18
Discovery of Novel Sertraline Derivatives as Potent Anti-Cryptococcus Agents
Li, W., Yun, Z., Ji, C., Tu, J., Yang, W., Li, J., Liu, N., & Sheng, C. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01845 · Cited by 18
A Proteomic Landscape of Candida albicans in the Stepwise Evolution to Fluconazole Resistance
Song, N., Zhou, X., Li, D., Li, X., & Liu, W. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02105-21 · Cited by 17
Bezerra, T. B., da Penha, A. A. G., da Silva, A. K. A., Ferreira, M. S., Lavor, S. D. F., Mendes, S. C., Quirino, G. D. S., & Pinto, A. G. A. (2022) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20221028c13 · Cited by 17
Yang, L., Tian, Z., Zhao, W., Zhang, J., Tian, C., Zhou, L., Jiao, Z., Peng, J., & Guo, G. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106679 · Cited by 17
Anti-Candidal Marine Natural Products: A Review
Arumugam, G., Gonçale, J. C., Rajaram, R., & Junqueira, J. C. (2023) · Journal of Fungi · doi:10.3390/jof9080800 · Cited by 18
Antifungal and antibiofilm activities of chromones against nine Candida species
Lee, J., Kim, Y., Kim, Y., & Lee, J. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01737-23 · Cited by 17
Hossain, S., Veri, A. O., Liu, Z., Iyer, K. R., O’Meara, T. R., Robbins, N., & Cowen, L. E. (2021) · Genetics · doi:10.1093/genetics/iyab095 · Cited by 19
Self-citationAlves, D. D. N., Martins, R. X., Ferreira, E. D. S., Alves, A. F., Andrade, J., Batista, T. M., Lazarini, J. G., Amorim, L. S., Rosalen, P. L., Farias, D. F., et al. (2021) · BioMed Research International · doi:10.1155/2021/2305695 · Cited by 17
Lin, C.-C., Hoo, S. Y., Ma, L., Lin, C., Huang, K.-F., Ho, Y.-N., Sun, C.-H., Lee, H., Chen, P.-Y., Shu, L., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03409-6 · Cited by 18
A Comparative Transcriptome Between Anti-drug Sensitive and Resistant Candida auris in China
Zhou, W., Li, X., Lin, Y., Yan, W., Jiang, S., Huang, X., Yang, X., Qiao, D., & Li, N. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.708009 · Cited by 16
Ge, X., Gao, M., He, B., Cao, N., Li, K., Liu, Y., Tang, S., Liu, K., Zhang, J., Hu, F., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121618 · Cited by 16
Cinnamaldehyde for the Treatment of Microbial Infections: Evidence Obtained from Experimental Models
Figueiredo, C. S. S. E. S., de Oliveira, P. V., Ferreira, L. D. R., de Sousa, T. J. D., do Nascimento, M. D. S., dos Santos, J. R. A., Zagmignan, A., Holanda, R. A., Galvão, L. C. D. C., & da Silva, L. C. N. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666221005105108 · Cited by 16
Gomaa, S. E., Abbas, H. A., Mohamed, F. A., Ali, M. A. M., Ibrahim, T. M., Halim, A. S. A., Alghamdi, M. A., Mansour, B., Chaudhary, A. A., Elkelish, A., et al. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03181-z · Cited by 16
Yang, W., Liu, R., Li, Z., Tu, J., Xu, D., Liu, N., & Sheng, C. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02331 · Cited by 16
Gao, Y. F., Zhang, R. Z., Xu, C., & Wang, M. (2024) · Organic Letters · doi:10.1021/acs.orglett.4c01275 · Cited by 16
Nayak, A., Khedri, A., Chavarria, A., Sanders, K. N., Ghalei, H., & Khoshnevis, S. (2024) · npj Antimicrobials and Resistance · doi:10.1038/s44259-024-00040-9 · Cited by 16
Fu, X., Tian, X., Lin, J., Wang, Q., Gu, L., Wang, Z., Chi, M., Yu, B., Feng, Z., Liu, W., et al. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s480800 · Cited by 16
Żyrek, D., Wajda, A., Czechowicz, P., Nowicka, J., Jaśkiewicz, M., Neubauer, D., & Kamysz, W. (2021) · Antibiotics · doi:10.3390/antibiotics10081001 · Cited by 16
Jiang, W., Zhou, M., Cong, Z., Xie, J., Zhang, W., Chen, S., Zou, J., Ji, Z., Shao, N., Chen, X., et al. (2022) · Angewandte Chemie · doi:10.1002/ange.202200778 · Cited by 16
Blanc, A. R., Sortino, M. A., Butassi, E., & Svetaz, L. A. (2023) · Phytomedicine Plus · doi:10.1016/j.phyplu.2023.100481 · Cited by 15
Expression pattern of drug-resistance genes ERG11 and TAC1 in Candida albicans Clinical isolates
Zare-Bidaki, M., Maleki, A., Ghanbarzadeh, N., & Nikoomanesh, F. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07878-0 · Cited by 15
Poulsen-Silva, E., Otero, C., Díaz-Cornejo, S., Atala, C., Fuentes, J. A., & Gordillo-Fuenzalida, F. (2024) · Fungal Biology Reviews · doi:10.1016/j.fbr.2024.100410 · Cited by 15
Ojo, O., Njanje, I., Abdissa, D., Swart, T., Higgitt, R. L., & Dorrington, R. A. (2025) · Natural Products and Bioprospecting · doi:10.1007/s13659-025-00501-2 · Cited by 16
Organoselenium Compounds As a Promising Source of Novel Antimicrobial Agents
Friberg, L. I. M., Blanchfield, J. T., & Blaskovich, M. A. T. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02460 · Cited by 16
Guevara-Lora, I., Braś, G., Juszczak, M., Karkowska‐Kuleta, J., Górecki, A., Manrique-Moreno, M., Dymek, J., Pyza, E., Kozik, A., & Rąpała‐Kozik, M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1045984 · Cited by 15
Metadata
- Authors
- Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Cowen, Leah E.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-05-22
- Volume
- 121
- Issue
- 6
- Pages
- 3390-3411
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- PMC
- PMC8519031
- OpenAlex
- W3026958586
- Cited by
- 801
- References
- 237
- Citations by year
- 2026: 109 · 2025: 192 · 2024: 168 · 2023: 133 · 2022: 132 · 2021: 63 · 2020: 4
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Chemical Reviews (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Canadian Institutes of Health Research (FDN-154288)
- National Institute of Allergy and Infectious Diseases (1R01AI127375-01)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- antifungal resistance, Candida albicans, Candida auris, Candida glabrata, invasive candidiasis, antifungal agents, molecular mechanisms of resistance, combination antifungal therapy, fungal virulence factors, emerging fungal pathogens
- MeSH terms
- Drug Development, Animals, Antifungal Agents, Candida, Candida albicans, Drug Therapy, Combination, Humans, Mycoses, Virulence, Molecular Structure, Signal Transduction, Drug Resistance, Fungal, Candida glabrata
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
